Free shipping on all U.S. orders over $250 · Local pickup available in Morgan Hill, CA
PureLab Performancepurelabperformance.com
FDA-approved drugImmune & Specialty ResearchPT-141

PT-141 (Bremelanotide)

Also known as: Bremelanotide

PT-141 (bremelanotide) is a synthetic peptide analog of alpha-melanocyte-stimulating hormone (alpha-MSH) that acts on melanocortin receptors. It has been studied in rodents and in two published Phase 3 human trials.

Evidence: strong · Peer-reviewed phase 3 human data

At a glance

Class
Melanocortin receptor agonist (alpha-MSH analog)
Developer
Palatin Technologies
FDA status
FDA-approved prescription drug (brand: Vyleesi). This page covers the research compound only.
Human data
Two randomized, double-blind, placebo-controlled Phase 3 trials (design-level only)
Animal / lab data
Female rat behavior studies; female Syrian hamster brain-expression study (2025)

Where it’s been studied

1
  • 1BrainMC3R/MC4R expression in reward circuitry, Syrian hamster (2025)

Mechanism studied

Bremelanotide is a peptide analog of alpha-MSH that activates melanocortin receptors [3]. A 2025 hamster study found MC3R and MC4R mRNA mostly in midbrain dopamine neurons, yet bremelanotide did not alter that reward circuit, so its central site of action remains under study [4].

What the research shows

StudyModelReported resultSource
RECONNECT integrated subgroup analyses [2]Human
Prespecified and integrated analyses of both Phase 3 trials, 1,202 participants
Coprimary endpoints examined across prespecified participant subgroups. Published.Peer-reviewed
Journal of Women's Health 2022
Bremelanotide and the mesolimbic circuit [4]Other animal
Female Syrian hamsters, brain mRNA mapping and conditioned place preference
MC3R/MC4R mRNA was mostly in VTA dopamine neurons; bremelanotide did not change receptor expression.Peer-reviewed
Neuropharmacology 2025

Human trials are listed for research context only; outcomes are reported in the linked publications. Animal and lab results do not establish effects in humans.

Supply

PureLab does not supply this compound. This page summarizes published research only.

More in Immune & Specialty Research

Sources

  1. Kingsberg SA et al. (2019). doi:10.1097/AOG.0000000000003500 Source
  2. Simon JA et al. (2022). doi:10.1089/jwh.2021.0225 Source
  3. Pfaus JG et al. (2004). doi:10.1073/pnas.0400491101 Source
  4. Borland JM et al. (2025). doi:10.1016/j.neuropharm.2025.110299 Source
For research use only. Not for human or veterinary use. Not a drug, food or cosmetic, and not intended to diagnose, treat, cure or prevent any disease. This library summarizes published research for educational purposes. PureLab Performance Inc.